---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008723"
form_type: "8-K"
ticker: "WGRX"
cik: "0002030763"
company_name: "Wellgistics Health, Inc."
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:29:59.919153+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Wellgistics Health partners with Tollo Health to market medical foods for GLP-1 side effects and Long COVID

## Summary
- Consulting agreement with Hudson Global Ventures: $250,000 fee + 52,000 shares for 30-day advisory services.
- Subsidiary Wellgistics LLC signs agreement with Tollo Health to market Tollo's medical foods for GLP-1 muscle loss and Long COVID.
- Tollo's first product is Galectovid, a proprietary medical food for dietary management of viral infections.
- GLP-1 drug market cited at $46.7B, expected to grow to $322B by 2034; 16M working-age Americans have Long COVID.
- Wellgistics expects cross-selling to grow customer base and become key supplier in GLP-1 and Long COVID markets.

## SEC filing metadata
- accession: 0001493152-25-008723
- form_type: 8-K
- ticker: WGRX
- cik: 0002030763
- company_name: Wellgistics Health, Inc.
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2030763/000149315225008723/0001493152-25-008723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2030763/000149315225008723/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008723
- JSON: https://secwatch.observer/filing/0001493152-25-008723.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.